Noninvasive brain pressure monitoring, anywhere it's needed
CranioSense is a clinical-stage medtech company developing IPASS, a noninvasive intracranial pressure monitoring device that measures ICP in seconds using a forehead patch and handheld sensors — no skull drilling required. The company targets traumatic brain injury, ICU, and emergency care settings where current invasive ICP methods are too risky to use broadly. CranioSense was awarded $5.5M in NIH and DoD federal grants in late 2024.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2025
Apr 2025
Create a free account to see which investors have funded this company.
Create Free AccountFitness wearable company offering a subscription-based health tracker that measures strain, recov...
Digital healthcare platform connecting patients, hospitals, and doctors in China for online consu...
Digital health insurance company and healthcare super-app offering personalized health insurance,...
operates in the healthcare industry focusing on biotechnology business
Workforce mental health platform that uses AI-powered matching to connect employees with high-qua...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
